Search Results
K. Stamatopoulos - Chronic lymphocytic leukemia: subset stories
Why is it important to risk stratify patients in CLL?
From the microenvironment to the CLL patient
CLL Horizons 2016: CLL 101. Drs Brian Koffman & Kostas Stamatopoulos
Dr Kostas Stamatopoulos on his research and patient empowerment work
BCR receptor sterotypes in CLL
What to look for in novel CLL therapies
CLL Horizons 2016: Treatment & Trials for High Risk CLL. Dr Kostas Stamatopoulos
How biomarkers can aid clinical decision making in CLL
The work of ERIC, the European Research Initiative on CLL
IMBB Seminar - Kostas STAMATOPOULOS, April 24th 2015 @ 12:00
Microenvironment of chronic lymphocytic leukaemia
